Novartis

R&D focused on manufacturing of drugs for multiple therapeutic areas

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 1996 groups126,000 employees language novartis.com

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
United States26.2%
India12%
Germany10.6%
Austria5.9%
United Kingdom5.1%

Innovation

10 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 11 times.

YearFilings
20121
20131
20154
20161
20211

Investor mix

11 investors on record.

Investor typeCountShare
Venture capital327%
Private equity19%
Accelerator & incubator218%
Bank & private debt19%
Other / undisclosed436%

Share of voice

Share of voice worldwide: 59.1% of web traffic across its competitive set.

Hiring activity

Hires periodically

27 roles tracked across 3 of the last 12 months

17 Feb 2026 · MSL Radioligand Therapy · Rotkreuz

12 Dec 2025 · Site Quality Head · Basel

7 Dec 2025 · Principal Scientist Oncology Translational Research · Basel

5 Dec 2025 · RLT Customer Solution & Strategy, Director · Basel

5 Dec 2025 · RLT Customer Excellence, Director · Basel

Based on job postings tracked across public sources.

Coming soon